Brand Comparison: Glucagon vs Gvoke – Key Differences
Published: July 15, 2026 17:12
Author: Paul Peña
Abstract: Glucagon and Gvoke are both injectable glucagon formulations for severe hypoglycemia, yet differ in composition, stability, and delivery. Gvoke (dasiglucagon) is a liquid-stable, ready-to-use solution, eliminating reconstitution errors, while traditional glucagon requires powder reconstitution. Market trends favor room-temperature stable, pre-filled devices. Gvoke offers superior pharmacokinetics (faster onset, consistent absorption) but higher cost. Regulatory approvals (FDA) and cold-chain logistics vary. For peptide product selection, prioritize stability, dosing accuracy, and patient adherence. The glucagon market is expanding with non-injectable alternatives, driving innovation in peptide delivery technologies.